ACE2 and CCR5 are receptors for the SARS-CoV-2 virus and the human immunodeficiency virus (HIV), respectively, and have been considered as therapeutic targets for viral infection (Michauld et al., 2020; Vangelista and Vento, 2018). The gene discussed is ACE2; the disease is viral infectious disease.